B3galnt2 - UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 2 Gene
Also Known as A930105D20Rik; D230016N13Rik
Species: Mus musculus
Summary
Predicted to enable acetylgalactosaminyltransferase activity. Predicted to be involved in protein O-linked glycosylation. Predicted to act upstream of or within UDP-N-acetylgalactosamine metabolic process. Predicted to be located in endoplasmic reticulum. Predicted to be active in Golgi membrane. Is expressed in submandibular gland primordium. Human ortholog(s) of this gene implicated in congenital muscular dystrophy-dystroglycanopathy type A11. Orthologous to human B3GALNT2 (beta-1,3-N-acetylgalactosaminyltransferase 2). [provided by Alliance of Genome Resources, Apr 2022]
B3galnt2 Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001362404.1 | NP_001349333.1 | UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 precursor |
| NM_001362405.1 | NP_001349334.1 | UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 precursor |
| NM_178640.3 | NP_848755.1 | UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-E70139 | UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2 | / | Unkown | |
| HY-RS01301 | B3GALNT2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service